admin

Drug Policy Webinar

by
DRUG TESTING POLICYThe Ins and Outs for Changing Times If you have drug testing policy questions, you have come to the right place. About This Session. Changing drug laws, a new administration, a dynamic and evolving drugs-of-abuse landscape and generational change in the makeup of our workforce have brought drug testing policy to the front ... Read more

Sarah Ashby Rejoins Psychemedics Corporation as Vice President, General Counsel

by
ACTON, Mass., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) announced that Sarah Ashby has rejoined the company as Vice President, General Counsel. In this important role, Sarah will be responsible for directing and managing all of the company’s legal activities. She will report directly to the company’s CEO. Sarah rejoins Psychemedics from ... Read more

Andrew Limbek Joins Psychemedics Corporation as Vice President, Controller

by
ACTON, Mass., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) announced that Andrew Limbek had joined the Company as Vice President, Controller. In this important role, Andrew will be responsible for directing and managing all of the Company’s financial activities, including external reporting and internal analysis. He will report directly to the Company’s ... Read more

Robyn C. Davis Joins Psychemedics Board of Directors

by
ACTON, Mass., March 17, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) announced that Robyn C. Davis was unanimously elected to serve on the Board of Directors of Psychemedics Corporation effective immediately. Ms. Davis will be filling the vacancy created by the untimely passing this past December of Clint Allen, a long-time and dedicated Psychemedics ... Read more

Are “New” Substance Abusers Slipping By Your Drug Test?

by
Are "New" Substance Abusers Slipping By Your Drug Test? This new year's challenges; some familiar and some not. “Your post-COVID workplace may be more vulnerable than ever. Be prepared .” The turn of a new year is when we resolve to reassess and adjust everything from our diets to our finances to our time spent ... Read more

Rebuilding A Workplace After COVID-19 (Part Three of Three)

by
Playing Defense. Things To Know About Detection & Deterrence. (Part Three of a Three-Part Series: “Rebuilding A Workplace After COVID-19”) “The best defense  is a good offense.” Conventional wisdom, locker room motivation, business tactic Offense is proactive. Defense is reactive. Founding Father George Washington, early 1900’s heavyweight boxing champion Jack Dempsey and legendary Green Bay ... Read more

Rebuilding A Workplace After COVID-19 (Part Two of Three)

by
A Shifting Threat and Why 70% is a Number To Remember (Part Two of a Three-Part Series: “Rebuilding A Workplace After COVID-19”) “… other types of disasters — have led people to increase their substance abuse.” -Dr. Adam Leventhal | University of Southern California | Health, Emotion and Addiction Laboratory A Quick Recap. In part ... Read more

Rebuilding A Workplace After COVID-19 (Part One of Three)

by
Stress, Self-Medication, and What History Teaches Us (Part One of a Three-Part Series: “Rebuilding A Workplace After COVID-19”) “The more you know about the past, the better prepared you are for the future.” - Theodore Roosevelt Looking backward to move forward. History truly is the best teacher for those wise enough to mine it for ... Read more

Psychemedics Announces a “Vaping Panel” to Detect and Deter the use of Marijuana, CBD and Nicotine

by

A New and Cost-Effective Tool to Combat the E-cigarette Epidemic Among Youth ACTON, MA, May 5, 2020 (GLOBE NEWSWIRE) — Psychemedics Corporation (NASDAQ: PMD), the world leader and pioneer in detecting drugs of abuse using hair analysis, today introduced a Vaping Panel to detect the use of Marijuana, CBD and Nicotine. This test provides a … Read more

Psychemedics Test for Cotinine (metabolite of Nicotine) Detection Cleared by FDA

by

A New and Cost-Effective Tool to Detect and Deter Nicotine use ACTON, MA, April 29, 2020 (GLOBE NEWSWIRE) — Psychemedics Corporation (NASDAQ: PMD), the world leader and pioneer in detecting drugs of abuse using hair analysis, today introduced the first FDA-cleared hair test for cotinine, the predominant metabolite for nicotine. This test provides a way … Read more